Not Yet Recruiting PHASE2 INTERVENTIONAL 2-arm NCT06251609

Naloxone for Opioid Associated Out of Hospital Cardiac Arrest (NOPACA)

Sponsor: University of California, San Francisco

Conditions Heart Arrest, Out-Of-Hospital Naloxone Opioid Overdose

Updated 4 times since 2024 Last updated: Mar 7, 2025 Started: Nov 30, 2026 Primary completion: Dec 31, 2028 Completion: Dec 31, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06251609, this PHASE2 trial focuses on Heart Arrest, Out-Of-Hospital and Naloxone and remains actively recruiting participants. Sponsored by University of California, San Francisco, it has been updated 4 times since 2026, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

4 versions recorded

Apr 2025 — Present [monthly]

Not Yet Recruiting PHASE2
Sep 2024 — Apr 2025 [monthly]

Not Yet Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE2
Mar 2024 — Jul 2024 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of California, San Francisco

Data source: University of California, San Francisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Francisco, United States